{"id":"W2627871710","doi":"10.1001/jama.2017.7112","title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers","year":2017,"lang":"en","type":"article","venue":"JAMA","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2863,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Sinai Health System; Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Cancer Institute; Pomorski Uniwersytet Medyczny W Szczecinie; Universität zu Köln; Centre Hospitalier Universitaire de Québec; Gentofte Hospital; Karolinska Institutet; Universität Wien; Medizinische Universität Wien; Peter MacCallum Cancer Centre; University of New South Wales; National Breast Cancer Foundation; Universitätsklinikum Köln; National Institute for Health and Care Research; Cancer Research UK; Deutschen Konsortium für Translationale Krebsforschung; QIMR Berghofer Medical Research Institute; Lunds Universitet; Deutsches Krebsforschungszentrum; Université Laval","keywords":"Medicine; Breast cancer; Oncology; Ovarian cancer; Mutation; Gynecology; Internal medicine; Cancer; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}